Full Length Research Paper
References
|
Ball N, Teo W, Chandra S, Chapman J (2019). Parkinson's Disease and the Environment. Frontiers in Neurology, Volume 10. |
|
|
Ben P, Zhang Z, Xuan C, Sun S, Shen L, Gao Y, Cao X, Zhou Y, Lan L, Yin Z, Luo L (2015). Protective Effect of l-Theanine on Cadmium-Induced Apoptosis in PC12 Cells by Inhibiting the Mitochondria-Mediated Pathway. Neurochemical Research 40(8): 1661-1670. |
|
|
Bonvallot N, Harrison P, Loh M (2010). WHO guidelines for indoor air quality: Selected pollutants. Copenhagen: WHO. |
|
|
Braak H, Rüb U, Gai WP, Tredici KD (2003). Idiopathic Parkinson's disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. Journal of Neural Transmission 110(5): 517-536. |
|
|
Braak H, Tredici KD, Rüb U, Vos RA, Steur EN, Braak E (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging 24(2): 197-211. |
|
|
Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu S (2004). Calcium, ATP, and ROS: A mitochondrial love-hate triangle. American Journal of Physiology-Cell Physiology 287:4. |
|
|
Catalá A, Díaz M (2016). Editorial: Impact of Lipid Peroxidation on the Physiology and Pathophysiology of Cell Membranes. Frontiers in Physiology, Volume 7. |
|
|
Chan FK, Moriwaki K, Rosa MJ (2013). Detection of Necrosis by Release of Lactate Dehydrogenase Activity. Methods in Molecular Biology Immune Homeostasis pp. 65-70. |
|
|
Channel SR, Latendresse JR, Kidney JK, Grabau JH, Lane JW, Steel-Goodwin L, Gothaus MC (1998). A Subchronic Exposure to Trichloroethylene Causes Lipid Peroxidation and Hepatocellular Proliferation in Male B6C3F1 Mouse Liver. Toxicological Sciences 43(2):145-154. |
|
|
Chatterjee S, Chatterjee A, Roy S, Bera B, Bandyopadhyay SK (2014). L-Theanine healed NSAID-induced gastric ulcer by modulating pro/antioxidant balance in gastric ulcer margin. Journal of Natural Medicines 68(4):699-708. |
|
|
Chen S, Wang Z, Ma Y, Zhang W, Lu J, Liang Y, Zheng X (2018). Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases. Molecules 23(3):512. |
|
|
Cheng H, Ulane CM, Burke RE (2010). Clinical progression in Parkinson disease and the neurobiology of axons. Annals of Neurology 67(6):715-725. |
|
|
Cho H, Kim S, Lee S, Park JA, Kim S, Chun HS (2008). Protective effect of the green tea component, l-theanine on environmental toxins-induced neuronal cell death. NeuroToxicology 29(4):656-662. |
|
|
Deb S, Dutta A, Phukan BC, Manivasagam T, Thenmozhi AJ, Bhattacharya P, Borah A (2019). Neuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeutics. Neurochemistry International 129:104478. |
|
|
DeMaagd G, Phillip A (2015). Parkinson's Disease and Its Management. Pharmacy and Therapeutics 40(8): 504-510. |
|
|
Doherty RE (2000). A History of the Production and Use of Carbon Tetrachloride, Tetrachloroethylene, Trichloroethylene and 1,1,1-Trichloroethane in the United States: Part 2--Trichloroethylene and 1,1,1-Trichloroethane. Environmental Forensics 1(2):83-93. |
|
|
Emamzadeh FN, Surguchov A (2018). Parkinson's Disease: Biomarkers, Treatment, and Risk Factors. Frontiers in Neuroscience P. 12. |
|
|
Gash DM, Rutland K, Hudson NL, Sullivan PG, Bing G, Cass WA, Prince TS (2008). Trichloroethylene: Parkinsonism and complex 1 mitochondrial neurotoxicity. Annals of Neurology 63(2):184-192. |
|
|
Goldman SM (2010). Trichloroethylene and Parkinson's disease: Dissolving the puzzle. Expert Review of Neurotherapeutics 10(6):835-837. |
|
|
Guehl D, Bezard E, Dovero S, Boraud T, Bioulac B, Gross C (1999). Trichloroethylene and parkinsonism: A human and experimental observation. European Journal of Neurology 6(5):609-611. |
|
|
Inamdar N, Arulmozhi D, Tandon A, Bodhankar S (2007). Parkinsons Disease: Genetics and Beyond. Current Neuropharmacology 5(2):99-113. |
|
|
Khare S, Gokulan K, Williams K, Bai S, Gilbert KM, Blossom SJ (2018). Irreversible effects of trichloroethylene on the gut microbial community and gut-associated immune responses in autoimmune-prone mice. Journal of Applied Toxicology 39(2):209-220. |
|
|
Krasnic T (2017). Preliminary Information on Manufacturing, Processing, Distribution, Use, and Disposal: Trichloroethylene [PDF]. United States Environmental Protection Agency. |
|
|
Li C, Tong H, Yan Q, Tang S, Han X, Xiao W, Tan Z (2016). L-Theanine Improves Immunity by Altering TH2/TH1 Cytokine Balance, Brain Neurotransmitters, and Expression of Phospholipase C in Rat Hearts. Medical Science Monitor 22:662-669. |
|
|
Liu M, Choi D, Hunter RL, Pandya JD, Cass WA, Sullivan PG, Bing G (2010). Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. Journal of Neurochemistry 112(3):773-783. |
|
|
Mahajan SD, Law W, Aalinkeel R, Reynolds J, Nair BB, Yong K, Schwartz SA (2012). Nanoparticle-Mediated Targeted Delivery of Antiretrovirals to the Brain. Methods in Enzymology Nanomedicine - Infectious Diseases, Immunotherapy, Diagnostics, Antifibrotics, Toxicology and Gene Medicine pp. 41-60. |
|
|
Muñoz E, Pastor P, Martí MJ, Valldeoriola F, Tolosa E, Oliva R (2001). Enfermedad de Parkinson esporádica y familiar: Estudio comparativo. Medicina Clínica 116(16):601-604. |
|
|
Nango H, Kosuge Y, Miyagishi H, Sugawa K, Ito Y, Ishige K (2017). Prostaglandin E2 facilitates neurite outgrowth in a motor neuron-like cell line, NSC-34. Journal of Pharmacological Sciences 135(2):64-71. |
|
|
Rietdijk CD, Perez-Pardo P, Garssen J, Wezel RJ, Kraneveld AD (2017). Exploring Braak's Hypothesis of Parkinson's Disease. Frontiers in Neurology P. 8. |
|
|
Russell HH, Matthews JE, Sewell GW (1992). TCE Removal from Contaminated Soil and Ground Water [PDF]. United States Environmental Protection Agency. |
|
|
Saqcena M, Menon D, Patel D, Mukhopadhyay S, Chow V, Foster DA (2013). Amino Acids and mTOR Mediate Distinct Metabolic Checkpoints in Mammalian G1 Cell Cycle. PLoS ONE 8:8. |
|
|
Sharma N, Nehru B (2017). Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model. Inflammopharmacology 26(2):349-360. |
|
|
Sharma RK, Candelario-Jalil E, Feineis D, Bringmann G, Fiebich BL, Akundi RS (2017). 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Alters Cell Cycle Progression in Human Neuroblastoma Cell Lines. Neurotoxicity Research 32(4):649-660. |
|
|
Sugiyama T, Sadzuka Y, Tanaka K, Sonobe T (2001). Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin. Toxicology Letters 121(2):89-96. |
|
|
Thangarajan S, Deivasigamani A, Natarajan SS, Krishnan P, Mohanan SK (2014). Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum. International Journal of Neuroscience 124(9):673-684. |
|
|
Triarhou LC (2013). Dopamine and Parkinson's Disease. Austin, Texas: Landes Bioscience. |
|
|
Yokogoshi H, Terashima T (2000). Effect of theanine, r-glutamylethylamide, on brain monoamines, striatal dopamine release and some kinds of behavior in rats. Nutrition 16(9):776-777. |
|
|
Yulug B, Ozansoy M, Cankaya S (2019). A different view on the pathophysiology of Parkinson's disease: A descendent neurochemical hypothesis? Neural Regeneration Research 14(10):1717. |
|
|
Zaheer F, Slevin JT (2011). Trichloroethylene and Parkinson Disease. Neurologic Clinics 29(3):657-665. |
|
|
Zhu Q, Shen T, Ding R, Liang Z, Zhang X (2005). Cytotoxicity of trichloroethylene and perchloroethylene on normal human epidermal keratinocytes and protective role of Vitamin E. Toxicology 209(1):55-67. |
|
|
Ziv I, Zilkha-Falb R, Offen D, Shirvan A, Barzilai A, Melamed E (1997). Levodopa induces apoptosis in cultured neuronal cells-A possible accelerator of nigrostriatal degeneration in Parkinson's disease? Movement Disorders 12(1):17-23. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
